The multifaceted role of BST2 in oncogenesis is well documented across various malignancies, where it modulates processes such as the EMT, the acquisition of drug resistance in CAR T-cell therapies, and the function of tumor-associated macrophages in pancreatic cancer [32–34]. The gene discussed is BST2; the disease is familial pancreatic carcinoma.